Cargando…

Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers

BACKGROUND: Both in endemic countries and in imported malaria, changes in total and differential leukocyte count during Plasmodium falciparum infection have been described. To study the exact dynamics of differential leukocyte counts and their ratios, they were monitored in a group of healthy non-im...

Descripción completa

Detalles Bibliográficos
Autores principales: van Wolfswinkel, Marlies E., Langenberg, Marijke C. C., Wammes, Linda J., Sauerwein, Robert W., Koelewijn, Rob, Hermsen, Cornelus C., van Hellemond, Jaap J., van Genderen, Perry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681833/
https://www.ncbi.nlm.nih.gov/pubmed/29126422
http://dx.doi.org/10.1186/s12936-017-2108-1
_version_ 1783277991530332160
author van Wolfswinkel, Marlies E.
Langenberg, Marijke C. C.
Wammes, Linda J.
Sauerwein, Robert W.
Koelewijn, Rob
Hermsen, Cornelus C.
van Hellemond, Jaap J.
van Genderen, Perry J.
author_facet van Wolfswinkel, Marlies E.
Langenberg, Marijke C. C.
Wammes, Linda J.
Sauerwein, Robert W.
Koelewijn, Rob
Hermsen, Cornelus C.
van Hellemond, Jaap J.
van Genderen, Perry J.
author_sort van Wolfswinkel, Marlies E.
collection PubMed
description BACKGROUND: Both in endemic countries and in imported malaria, changes in total and differential leukocyte count during Plasmodium falciparum infection have been described. To study the exact dynamics of differential leukocyte counts and their ratios, they were monitored in a group of healthy non-immune volunteers in two separate Controlled Human Malaria Infection (CHMI) studies. METHODS: In two CHMI trials, CHMI-a and CHMI-b, 15 and 24 healthy malaria-naïve volunteers, respectively, were exposed to bites of infected mosquitoes, using the P. falciparum research strain NF54 and the novel clones NF135.C10 and NF166.C8. After mosquito bite exposure, twice-daily blood draws were taken to detect parasitaemia and to monitor the total and differential leukocyte counts. All subjects received a course of atovaquone–proguanil when meeting the treatment criteria. RESULTS: A total of 39 volunteers participated in the two trials. Thirty-five participants, all 15 participants in CHMI-a and 20 of the 24 volunteers in CHMI-b, developed parasitaemia. During liver stage development of the parasite, the median total leukocyte count increased from 5.5 to 6.1 × 10(9) leukocytes/L (p = 0.005), the median lymphocyte count from 1.9 to 2.2 (p = 0.001) and the monocyte count from 0.50 to 0.54 (p = 0.038). During the subsequent blood stage infection, significant changes in total and differential leukocyte counts lead to a leukocytopenia (nadir median 3.3 × 10(9) leukocytes/L, p = 0.0001), lymphocytopenia (nadir median 0.7 × 10(9) lymphocytes/L, p = 0.0001) and a borderline neutropenia (nadir median 1.5 × 10(9) neutrophils/L, p = 0.0001). The neutrophil to lymphocyte count ratio (NLCR) reached a maximum of 4.0. Significant correlations were found between parasite load and absolute lymphocyte count (p < 0.001, correlation coefficient − 0.46) and between parasite load and NLCR (p < 0.001, correlation coefficient 0.50). All parameters normalized after parasite clearance. CONCLUSIONS: During the clinically silent liver phase of malaria, an increase of peripheral total leukocyte count and differential lymphocytes and monocytes occurs. This finding has not been described previously. This increase is followed by the appearance of parasites in the peripheral blood after 2–3 days, accompanied by a marked decrease in total leukocyte count, lymphocyte count and the neutrophil count and a rise of the NLCR. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-017-2108-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5681833
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56818332017-11-17 Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers van Wolfswinkel, Marlies E. Langenberg, Marijke C. C. Wammes, Linda J. Sauerwein, Robert W. Koelewijn, Rob Hermsen, Cornelus C. van Hellemond, Jaap J. van Genderen, Perry J. Malar J Research BACKGROUND: Both in endemic countries and in imported malaria, changes in total and differential leukocyte count during Plasmodium falciparum infection have been described. To study the exact dynamics of differential leukocyte counts and their ratios, they were monitored in a group of healthy non-immune volunteers in two separate Controlled Human Malaria Infection (CHMI) studies. METHODS: In two CHMI trials, CHMI-a and CHMI-b, 15 and 24 healthy malaria-naïve volunteers, respectively, were exposed to bites of infected mosquitoes, using the P. falciparum research strain NF54 and the novel clones NF135.C10 and NF166.C8. After mosquito bite exposure, twice-daily blood draws were taken to detect parasitaemia and to monitor the total and differential leukocyte counts. All subjects received a course of atovaquone–proguanil when meeting the treatment criteria. RESULTS: A total of 39 volunteers participated in the two trials. Thirty-five participants, all 15 participants in CHMI-a and 20 of the 24 volunteers in CHMI-b, developed parasitaemia. During liver stage development of the parasite, the median total leukocyte count increased from 5.5 to 6.1 × 10(9) leukocytes/L (p = 0.005), the median lymphocyte count from 1.9 to 2.2 (p = 0.001) and the monocyte count from 0.50 to 0.54 (p = 0.038). During the subsequent blood stage infection, significant changes in total and differential leukocyte counts lead to a leukocytopenia (nadir median 3.3 × 10(9) leukocytes/L, p = 0.0001), lymphocytopenia (nadir median 0.7 × 10(9) lymphocytes/L, p = 0.0001) and a borderline neutropenia (nadir median 1.5 × 10(9) neutrophils/L, p = 0.0001). The neutrophil to lymphocyte count ratio (NLCR) reached a maximum of 4.0. Significant correlations were found between parasite load and absolute lymphocyte count (p < 0.001, correlation coefficient − 0.46) and between parasite load and NLCR (p < 0.001, correlation coefficient 0.50). All parameters normalized after parasite clearance. CONCLUSIONS: During the clinically silent liver phase of malaria, an increase of peripheral total leukocyte count and differential lymphocytes and monocytes occurs. This finding has not been described previously. This increase is followed by the appearance of parasites in the peripheral blood after 2–3 days, accompanied by a marked decrease in total leukocyte count, lymphocyte count and the neutrophil count and a rise of the NLCR. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-017-2108-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-10 /pmc/articles/PMC5681833/ /pubmed/29126422 http://dx.doi.org/10.1186/s12936-017-2108-1 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
van Wolfswinkel, Marlies E.
Langenberg, Marijke C. C.
Wammes, Linda J.
Sauerwein, Robert W.
Koelewijn, Rob
Hermsen, Cornelus C.
van Hellemond, Jaap J.
van Genderen, Perry J.
Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers
title Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers
title_full Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers
title_fullStr Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers
title_full_unstemmed Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers
title_short Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers
title_sort changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve dutch volunteers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681833/
https://www.ncbi.nlm.nih.gov/pubmed/29126422
http://dx.doi.org/10.1186/s12936-017-2108-1
work_keys_str_mv AT vanwolfswinkelmarliese changesintotalanddifferentialleukocytecountsduringtheclinicallysilentliverphaseinacontrolledhumanmalariainfectioninmalarianaivedutchvolunteers
AT langenbergmarijkecc changesintotalanddifferentialleukocytecountsduringtheclinicallysilentliverphaseinacontrolledhumanmalariainfectioninmalarianaivedutchvolunteers
AT wammeslindaj changesintotalanddifferentialleukocytecountsduringtheclinicallysilentliverphaseinacontrolledhumanmalariainfectioninmalarianaivedutchvolunteers
AT sauerweinrobertw changesintotalanddifferentialleukocytecountsduringtheclinicallysilentliverphaseinacontrolledhumanmalariainfectioninmalarianaivedutchvolunteers
AT koelewijnrob changesintotalanddifferentialleukocytecountsduringtheclinicallysilentliverphaseinacontrolledhumanmalariainfectioninmalarianaivedutchvolunteers
AT hermsencornelusc changesintotalanddifferentialleukocytecountsduringtheclinicallysilentliverphaseinacontrolledhumanmalariainfectioninmalarianaivedutchvolunteers
AT vanhellemondjaapj changesintotalanddifferentialleukocytecountsduringtheclinicallysilentliverphaseinacontrolledhumanmalariainfectioninmalarianaivedutchvolunteers
AT vangenderenperryj changesintotalanddifferentialleukocytecountsduringtheclinicallysilentliverphaseinacontrolledhumanmalariainfectioninmalarianaivedutchvolunteers